Effect of exposure to typical phthalate esters on estrogen homeostasis during pregnancy
10.19428/j.cnki.sjpm.2022.22030
- VernacularTitle:典型邻苯二甲酸酯类物质暴露与孕期雌激素稳态的联系
- Author:
Linying WU
1
;
Zichen YANG
2
;
Dongliang XUAN
1
;
Yuanping WANG
2
;
Jing TIAN
1
;
Yi WANG
2
;
Minghui HAN
2
;
Hexing WANG
2
;
Qian PENG
1
;
Qingwu JIANG
2
Author Information
1. Jiading District for Disease Control and Prevention， Shanghai 201899， China
2. School of Public Health， Fudan University， Shanghai 200032， China
- Publication Type:Journal Article
- Keywords:
phthalate;
estrogen;
estrogen homeostasis;
pregnant woman;
pregnancy
- From:
Shanghai Journal of Preventive Medicine
2022;34(7):623-628
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo study the relationship between the exposure to two kinds of phthalate esters （PAEs） ［Di-N-butyl phthalate，（DBP） and Di-（2-ethylhexyl）phthalate （DEHP）］ and estrogen homeostasis in pregnant women. MethodsIn 2021， we classified the Jiading District of Shanghai into five geographical areas， east， west， south， north and central. A total of 151 pregnant women from each area were selected for questionnaire survey， with random urine samples during first， second， and third trimesters collected. A DBP metabolite ［Mono-N-butyl phthalate （MBP）］ and two DEHP metabolites ［Mono（2-ethylhexyl） phthalate （MEHP）， Mono（2-ethyl5-oxohexyl） phthalate， （MEOHP）］ and three estrogens ［estrone （E1）， 17β -estradiol （E2）， and estriol （E3）］ in urine were determined by ultra-performance liquid chromatography tandem quadrupole time-of-flight mass spectrometry. After a natural logarithmic transformation of PAEs metabolite levels and estrogen concentration， multivariable linear regression was used to control potential confounders and determine the relationship between PAEs metabolite levels and estrogen concentration. ResultsThe detection rates of three PAEs metabolites in urine of pregnant women were more than 98%. The median corrected concentrations of MBP， MEHP and MEOHP were 5.18， 0.59 and 4.23 mg·kg-1， respectively. During the whole pregnancy， MEOHP was positively correlated with E1 （β=0.450， 95%CI： 0.057‒0.844）， and MBP was positively correlated with E3 （β=0.250， 95%CI： 0.034‒0.465）. Stratified by trimesters， MBP was positively correlated with E3 in the first trimester （β=0.428， 95%CI： 0.103‒0.752）. MEOHP was positively correlated with E1 in the second trimester （β=0.734， 95%CI： 0.130‒0.752）， and had a possitive trend with E1 in the third trimester （β=0.744， 95%CI： -0.140‒1.629）. In addition， MEHP had a negative correlation with E1 in the second trimester （β=-0.498， 95%CI： -1.063‒0.066）. MEOHP had a positive correlation trend with E2 （β=0.628， 95%CI： -0.101‒1.356） in the third trimester. ConclusionPAEs exposure may interfere with estrogen homeostasis during pregnancy and differs by trimesters. Given the cross-sectional nature of this study， it warrants further study to validate the findings.
